Kaat (PhD STAT) is Epidemiology Business Lead at P95. She is PI of id.DRIVE and author of “Vaccination Programmes: Epidemiology, Monitoring, Evaluation”.
P95 has its headquarters in Europe (Leuven, Belgium) and regional hubs in Latin America (Bogota, Colombia), Southeast Asia (Bangkok) and Africa (Johannesburg and Cape Town, South Africa). At both the headquarters and the regions we offer a wide range of services including study setup, initiation and management, medical monitoring, data management, statistics, medical writing, epidemiology, sample management, site monitoring. P95 offers these services with a team of medical doctors, epidemiologists, data scientists, medical writers, IT engineers, pharmacovigilance specialists, administrative staff, project/study operation managers, project support officers, and clinical research associates (CRAs). P95 has recently completed a merger with OnQ Research, a South Africa-based contract research organisation (CRO) offering clinical research services. OnQ is a full-service CRO.
Kaat Bollaerts is a PhD-level biostatistician with over 15 years of experience in the field of vaccine epidemiology. Kaat joined P95 in September 2013, and is currently Epidemiology Business Lead responsible for all RWE studies within P95. Kaat is also the Principal Investigator of the id.DRIVE studies (https://iddrive.eu) and co-authors the book “Vaccination Programmes: Epidemiology, Monitoring, Evaluation” (Hahné, Bollaerts, Farrington).
Additional questions
How would you categorise yourself?
ResearcherBusiness DeveloperService provider
Organisation Type
Professional Services & ConsultingContract Research Organizations (CRO)
Areas of expertise
Data management, analytics and monitoringClinical development and trialsReal World Data